Related Experiment Video
Updated: May 27, 2026
02:55
Arteriovenous Metabolomics to Measure In Vivo Metabolite Exchange in Brown Adipose Tissue
Published on: October 6, 2023
Metabolomics and cardiovascular biomarker discovery
Eugene P Rhee1, Robert E Gerszten
1Nephrology Division, Massachusetts General Hospital, Boston, MA, USA.
Clinical Chemistry
|November 24, 2011
Summary
Metabolomics, the study of metabolites, aids biomarker discovery for diseases like diabetes. Understanding metabolite patterns is key to identifying new disease indicators.
Area of Science:
- Biochemistry
- Biomarker Discovery
Background:
- Metabolomics analyzes biochemical compounds for biomarker discovery.
- No single method covers the entire metabolome; NMR and MS are common techniques.
- Careful study design is crucial to minimize confounding factors like diet and comorbidities.
Purpose of the Study:
- To explore the application of metabolomics in human biomarker discovery.
- To understand the relationship between metabolites and disease risk markers.
Main Methods:
- Utilizing Nuclear Magnetic Resonance spectroscopy (NMR) and Mass Spectrometry (MS) for metabolite analysis.
- Employing targeted and non-targeted (pattern-recognition) approaches.
- Applying metabolite profiling in both small-scale interventions and large epidemiological cohorts.
Main Results:
- Metabolite profiling reveals metabolic disturbances associated with human diseases.
- Identified relationships between metabolites and established risk markers for diabetes and renal failure.
Conclusions:
- Metabolite profiling highlights metabolic disturbances in human diseases across various study designs.
- Further experimental and functional genomic studies are needed to establish causal links between biomarkers and disease pathogenesis.
Related Concept Videos
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...